Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC1 | P33527 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | GSR | P00390 | 3/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.54 |
| ▸ | CA12 | O43570 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1547530 | 0.97 | ABCC1 (0.94) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1547974 | 0.91 | ABCC1 (0.83) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1547730 | 0.88 | GSR (0.81) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1547962 | 0.83 | ABCC1 (0.71) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1547742 | 0.83 | ABCC1 (0.71) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1547817 | 0.83 | ABCC1 (0.71) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1547686 | 0.83 | ABCC1 (0.71) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1548118 | 0.83 | ABCC1 (0.71) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1547733 | 0.82 | GSR (1.00) | ABCC1ALDH1A1MAPTGMNNLMNA | |
| SCHEMBL1548123 | 0.82 | GSR (0.71) | ABCC1ALDH1A1MAPTGMNNLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025230907-A1 | A CXCR4 ANTAGONIST, A STATS ACTIVATOR, AND/OR AN AGENT THAT INCREASES NITRIC OXIDE CONTENT FOR USE IN METHODS OF IMPROVING NERVE REGENERATION | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-06 | — | — | WO | claimed |
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-118742325-A | Methods for preventing or treating diseases or conditions associated with antineoplastic agents | 上海岸阔医药科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| EP-4426274-A1 | NITRIC OXIDE DONORS FOR USE IN SURGICAL RECOVERY | Baxter International Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| US-20240285831-A1 | METHODS OF USE OF MODULATORS TO IMPROVE NERVE REGENERATION | KEEFER, Edward (US) | 2024-08-29 | — | — | US | claimed |
| US-11969522-B2 | Use of immune modulators to improve nerve regeneration | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-04-30 | — | — | US | claimed |
| WO-2023142996-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | 上海岸阔医药科技有限公司 | 2023-08-03 | — | — | WO | claimed |
| WO-2023081681-A1 | NITRIC OXIDE DONORS FOR USE IN SURGICAL RECOVERY | BAXTER INTERNATIONAL INC. (US) | 2023-05-11 | — | — | WO | claimed |
| US-20230140515-A1 | NITRIC OXIDE DONORS FOR USE IN SURGICAL RECOVERY | BAXTER INTERNATIONAL INC. | 2023-05-04 | — | — | US | claimed |
| US-20180036314-A1 | METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | EXODOS LIFE SCIENCES LP (US) | 2018-02-08 | — | — | US | claimed |
| WO-2016065423-A1 | METHOD AND COMPOSITIONS FOR PREVENTING BACTERIAL CORROSION OF A SUBSTRATE | IXOM OPERATIONS PTY LTD (AU) | 2016-05-06 | — | — | WO | claimed |
| CN-103429235-A | Compounds for treating cancer and uses thereof | LAI HUNG-CHENG | 2013-12-04 | — | — | CN | claimed |
| US-20130261142-A1 | COMPOUNDS USED FOR TREATING CANCER AND THE USE THEREOF | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2013-10-03 | — | — | US | claimed |
| US-20130053393-A1 | METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | EXODOS LIFE SCIENCES LIMITED PARTNERSHIP (US) | 2013-02-28 | — | — | US | claimed |
| EP-2512479-A1 | METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | Exodos Life Sciences Limited Partnership (US) | 2012-10-24 | — | — | EP | claimed |
| WO-2012079232-A1 | COMPOUNDS USED FOR TREATING CANCER AND THE USE THEREOF | LAI HUNG-CHENG (CN) | 2012-06-21 | — | — | WO | claimed |
| WO-2011075655-A1 | METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | EXODOS LIFE SCIENCES LIMITED PARTNERSHIP (US) | 2011-06-23 | — | — | WO | claimed |
| US-7910574-B2 | Treatments for the control of schistosomiasis | ILLINOIS STATE UNIVERSITY (US) | 2011-03-22 | — | — | US | claimed |
| WO-2026107071-A1 | COMBINATION THERAPY | Retension Pharmaceuticals, Inc. (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-1998005689-A1 | POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO | DUKE UNIVERSITY MEDICAL CENTER (US) | 1998-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240285831-A1 | METHODS OF USE OF MODULATORS TO IMPROVE NERVE REGENERATION | CXCR3, CXCL12, CXCR4 | ABCC1 4160/4885ALDH1A1 2426/4885MAPT 4089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.